CDKN2A/B homozygous deletions were previously identified as a negative prognostic factor in IDH-mutant astrocytomas in update 5 of the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy. This evidence concerns the gene IDH1 and central nervous system neoplasm.